Nerea Varo Cenarruzabeitia-rekin lankidetzan egindako argitalpenak (18)

2024

  1. Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome

    Clinica Chimica Acta, Vol. 557

2022

  1. Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

    OncoImmunology, Vol. 11, Núm. 1

2020

  1. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

2019

  1. Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss

    Clinical Endocrinology, Vol. 91, Núm. 3, pp. 391-399

  2. Trabecular bone score in active or former smokers with and without COPD

    PLoS ONE, Vol. 14, Núm. 2

2015

  1. IL-8 gene variants are associated with lung function decline and multidimensional BODE index in COPD patients but not with disease susceptibility: A validation study

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 12, Núm. 1, pp. 55-61

  2. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

    Liver International, Vol. 35, Núm. 5, pp. 1590-1596

2014

  1. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

    Clinical Biochemistry, Vol. 47, Núm. 18, pp. 272-278

2013

  1. Erratum: Traditional and novel bone remodeling markers in premenopausal and postmenopausal women (Journal of Clinical Endocrinology and Metabolism (2013) 98 (E1740-E1748) DOI:10.1210/jc.2013-2264)

    Journal of Clinical Endocrinology and Metabolism

  2. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 11

2012

  1. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD

    Respiratory Research, Vol. 13

  2. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, Núm. 6, pp. 1477-1487

2011

  1. Gender differences in plasma biomarker levels in a cohort of COPD patients: A pilot study

    PLoS ONE, Vol. 6, Núm. 1

  2. TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study

    BMC Medical Genetics, Vol. 12

2010

  1. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, Núm. 5

2008

  1. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 294, Núm. 1

  2. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 6, pp. 2319-2327

2005

  1. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632